cisplatin

Documents about cisplatin

• Evaluation of the Effect of N-acetylcysteine in Preventing Cisplatin-Induced Toxicities in Cancer Patients#1115259ClinicalTrials.gov
• Prevention of Cisplatin-Induced Hearing Loss by Intratympanic Dexamethasone Treatment#917223ClinicalTrials.gov
• Effects of DPP4 Inhibitor on Cisplatin Induced Acute Kidney Injury#873282ClinicalTrials.gov
• Protection From Cisplatin Ototoxicity by Lactated Ringers#1419447ClinicalTrials.gov
• Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine and Sodium Thiosulfate#1445002ClinicalTrials.gov
• Cisplatin Disposition and Kidney Injury#897957ClinicalTrials.gov
• Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma#1094490ClinicalTrials.gov
• Treatment of Radiation and Cisplatin Induced Toxicities with Tempol#1095534ClinicalTrials.gov
• Transtympanic STS Against Cisplatin-induced SNHL: the SOUND Trial#1213963ClinicalTrials.gov
• IMRT/Pemetrexed/Cisplatin in Esophageal Cancer#1321461ClinicalTrials.gov
• NAC to Prevent Cisplatin-induced Hearing Loss#856438ClinicalTrials.gov
• Trial of S-1 Plus Cisplatin (SP) Versus Gemcitabine Plus Cisplatin (GP) in Advanced Biliary Tract Adenocarcinoma#1418856ClinicalTrials.gov
• Docetaxal & Cisplatin vs LDFRT + Docetaxal & Cisplatin in Locally Advanced NPC#829183ClinicalTrials.gov
• Phase III Study of S-1 + Cisplatin vs Cisplatin in Cervical Cancer#874631ClinicalTrials.gov
• Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma#910946ClinicalTrials.gov
• Guidance on the short hydration method for cisplatin administration#1001660OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Weekly IV Topotecan and Cisplatin With Radiation in Cervical Carcinoma#1045590ClinicalTrials.gov
• Trial With Taxotere and Cisplatin in Non-operable Adrenocortical Carcinoma#1261571ClinicalTrials.gov
• GEM/Cisplatin/S-1 vs GEM/Cisplatin for Biliary Tract Cancer#1279768ClinicalTrials.gov
• Cisplatin vs Paclitaxel for Triple Negative Breast Cancer#1294889ClinicalTrials.gov
• Sub-nephrotoxic cisplatin sensitizes rats to acute renal failure and increases urinary excretion of fumarylacetoacetase#337358Gestión del Repositorio Documental de la Universidad de Salamanca
• Topotecan Plus Cisplatin Versus Etoposide Plus Cisplatin In 1st Line Extensive Disease Small Cell Lung Cancer#966460ClinicalTrials.gov
• Protective Role of N-acetylcisteine From Cisplatin-induced Ototoxicity in Patients With Head and Neck Cancer#1433004ClinicalTrials.gov
• Comparison of Rapamycin and 3-Methyladenine in Cisplatin-Induced Experimental Cardiotoxicity#256621İzmir Yüksek Teknoloji Enstitüsü
• Evaluation of the Effect of Acetazolamide, Mannitol and N-acetylcysteine on Cisplatin-Induced Nephrotoxicity#806245ClinicalTrials.gov
• Testis CAB: Cabazitaxel as Salvage Treatment for Cisplatin-resistant Germ Cell Cancer#834811ClinicalTrials.gov
• Study of OTO-104 in Subjects at Risk From Cisplatin-Induced Hearing Loss#894993ClinicalTrials.gov
• Tri-weekly Cisplatin Based Chemoradiation in Locally Advanced Cervical Cancer#1339907ClinicalTrials.gov
• Taxotere/Temodar/Cisplatin Study in Melanoma Patients#1421228ClinicalTrials.gov
• Gemcitabine-Carboplatin Versus Gemcitabine-Oxaliplatin in Cisplatin-unfit Urothelial Carcinoma#1436621ClinicalTrials.gov
• Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLC#1211873ClinicalTrials.gov
• Docetaxol Plus Cisplatin Versus 5-Fu Plus Cisplatin as 1st-line Chemotherapy in Advanced ESCC Patients#1432994ClinicalTrials.gov
• Pemetrexed/Cisplatin Versus Gemcitabine/Cisplatin According to Thymidylate Synthase Expression#884969ClinicalTrials.gov
• ABX Combined With Cisplatin Compared With Gemcitabine Combined With Cisplatin in NSCLC#1074776ClinicalTrials.gov
• Trial of Erlotinib, Gemcitabine and Cisplatin in Metastatic Pancreatic Cancer#1293792ClinicalTrials.gov
• Phase II Trial of Preoperative Combined Modality Therapy for Esophageal Carcinoma: Cisplatin-Irinotecan Followed by Radiation Therapy With Concurrent Cisplatin and Irinotecan.#859613ClinicalTrials.gov
• Cisplatin HAI Study in Patients With Advanced Cancer and Dominant Liver Involvement#886361ClinicalTrials.gov
• Cisplatin Desensitization in a Patient with Nasopharyngeal Carcinoma Experiencing Urticarial Allergic to Cisplatin#930415Acta Interna: The Journal of Internal Medicine
• Temozolomide, Cisplatin, and Nivolumab in People With Colorectal Cancer#847303ClinicalTrials.gov
• Efficacy Study for Postoperative Chemoradiation Using Triweekly Cisplatin in Cervical Cancer Patients#857078ClinicalTrials.gov
• Study of NGR-hTNF in Combination With Cisplatin in Solid Tumor#1045529ClinicalTrials.gov
• Study of Temsirolimus, Erlotinib and Cisplatin in Solid Tumors#1183280ClinicalTrials.gov
• Cisplatin-based and Carboplatin-based Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma#1371918ClinicalTrials.gov
• Docetaxel, Cetuximab and Cisplatin Followed by Radiation, Cetuximab and Cisplatin in Head and Neck Cancer#1438615ClinicalTrials.gov
• Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer#884947ClinicalTrials.gov
• Genetic Determinants of Response to Neoadjuvant Cisplatin-based Chemotherapy in Urothelial Cancer#899386ClinicalTrials.gov
• Gemcitabine-Cisplatin-90Y TARE for Unresectable Intrahepatic Cholangiocarcinoma#1093707ClinicalTrials.gov
• Adjuvant Cisplatin and Docetaxel in Non Small Cell Lung Cancer#1351703ClinicalTrials.gov
• Intratympanic Steroid Treatment For The Prevention Of Inner Ear Toxicity Associated With Systemic Treatment With Cisplatin.#1418343ClinicalTrials.gov
• Adjuvant Capecitabine vs Gemcitabine Plus Cisplatin in Resected Extrahepatic Cholangiocarcinoma#1439589ClinicalTrials.gov